An interventional study of Kinesio Taping and Standard Postoperative Rehabilitation in Rotator Cuff Tears, Shoulder Pain and Post Operative Pain, sponsored by Olcay Yavuz. Completed at 1 site in Turkey (Türkiye). Open to participants aged 40 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Olcay Yavuz · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 85 studies in Rotator Cuff Injuries with a site in Turkey — 19 open to participants now, 22 under way, none of them phase 3. Rotator Cuff Injuries · Turkey.
Among the 85 studies in Rotator Cuff Injuries with a site in Turkey, this one is the 21st largest by enrollment of the 63 interventional ones that give a count, is one of 13 that started in 2026, is one of 63 with no phase, and was the 74th registered.
632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.
Browse Rotator Cuff Injuries studies →19 of the 85 studies in Rotator Cuff Injuries with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul Medeniyet University · Sites in Turkey
Ages 18+ · Healthy volunteers
Firat University · Sites in Turkey
Ages 18–65
Ahi Evran University Education and Research Hospital · Sites in Turkey
Ages 40–60
Istanbul Nisantasi University · Sites in Turkey
Ages 18–75
Balikesir Ataturk City Hospital · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.
This study: 40 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
85 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 13 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 52 is below the median of 60 across 456 interventional studies indexed under Rotator Cuff Injuries.
Median enrollment 44 across the 63 interventional studies, 50 across the 22 observational. Of the 58 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 85 has an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Olcay Yavuz as lead sponsor.
Olcay Yavuz has 1 study filed under Rotator Cuff Injuries — fewer than ten, so there is no comparison to draw.
3 of the studies in Rotator Cuff Injuries with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07377292Ahi Evran University Education and Research HospitalEffectiveness of Core Stabilization Exercises in Rotator Cuff Injuries | 2026-12-25 |
| NCT07853950Ataturk UniversityFibrin Clot Augmentation in Arthroscopic Rotator Cuff Repair | 2027-02-28 |
| NCT07428070Istanbul Nisantasi UniversityContextually Enhanced Exercise Programs for Rotator Cuff-Related Shoulder Pain | 2027-05-06 |
Add all 3 to your calendar (.ics) → With an account.
Among the 85 studies in Rotator Cuff Injuries with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective randomized controlled trial evaluated whether adding Kinesio Taping (KT) to a standardized postoperative rehabilitation program improves early clinical recovery after arthroscopic rotator cuff repair. Patients undergoing arthroscopic repair of an isolated full-thickness supraspinatus tear were randomized to receive either standardized rehabilitation combined with KT or standardized rehabilitation alone. Postoperative pain intensity was the primary outcome. Secondary outcomes included shoulder range of motion, postoperative edema, Constant-Murley Score, QuickDASH score, and postoperative complications. Participants were assessed preoperatively and on postoperative day 1, week 2, week 6, and month 3.
This prospective, randomized controlled trial was designed to evaluate the effects of adding postoperative Kinesio Taping (KT) to a standardized rehabilitation program on pain, edema, shoulder range of motion, and functional recovery after arthroscopic rotator cuff repair.
Patients aged 40-70 years who underwent arthroscopic repair of an isolated full-thickness supraspinatus tear measuring 1-3 cm in the mediolateral dimension were eligible for inclusion. Tear size was confirmed intraoperatively using a calibrated arthroscopic probe. Only tears with Patte grade I-II tendon retraction and Goutallier grade 2 or lower fatty degeneration were included.
Patients with massive or multiple-tendon rotator cuff tears, subscapularis involvement, previous surgery on the affected shoulder, glenohumeral arthritis, systemic inflammatory disease, diabetes mellitus, smoking history, or a known allergy to adhesive or kinesiology tape were excluded.
After providing written informed consent, eligible participants were randomly assigned to one of two treatment groups using a computer-generated block randomization sequence with variable block sizes. Allocation concealment was maintained using sequentially numbered, sealed, opaque envelopes.
Participants in the intervention group received KT for 3 weeks in addition to the standardized postoperative rehabilitation program. KT was initiated on postoperative day 1 and reapplied every three days during the first four postoperative weeks, with each application maintained continuously for approximately 72 hours. Participants in the control group followed the same standardized postoperative rehabilitation program without taping. All KT applications were performed by the same certified physiotherapist using a standardized technique.
Because of the visible nature of the intervention, participants and outcome assessors were not blinded to group allocation. However, the assessors were not involved in generating the randomization sequence or concealing treatment allocation.
The primary outcome was postoperative pain intensity measured using the Visual Analog Scale (VAS). Secondary outcomes included shoulder forward flexion and abduction, postoperative edema, shoulder function measured using the Constant-Murley Score, upper-extremity disability measured using the QuickDASH questionnaire, and postoperative complications, including tape-related skin reactions.
Postoperative edema was assessed by measuring the circumference of the operated shoulder at a standardized point in the deltoid region and comparing it with the contralateral shoulder. Shoulder range of motion was measured using a standard goniometer. Each range-of-motion measurement was repeated three times, and the mean value was recorded.
Clinical assessments were performed preoperatively and on postoperative day 1, week 2, week 6, and month 3. Outcomes were compared between the two groups and evaluated longitudinally to determine whether the addition of KT influenced the pattern of early postoperative recovery following arthroscopic rotator cuff repair.
The criteria were revised on the registry on Sep 30, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group will receive standard postoperative rehabilitation following arthroscopic rotator cuff repair, in addition to kinesio taping applied for three weeks during the postoperative period.
Procedure: Kinesio Taping · Procedure: Standard Postoperative Rehabilitation
Participants in this group will receive standard postoperative rehabilitation alone following arthroscopic rotator cuff repair, without the application of kinesio taping.
Procedure: Standard Postoperative Rehabilitation
Application of kinesio taping to the operated shoulder during the postoperative period as an adjunct to standard rehabilitation.
Standard postoperative rehabilitation program following arthroscopic rotator cuff repair.
Pain Intensity (Visual Analog Scale, VAS)
Pain intensity will be assessed using the Visual Analog Scale (VAS) for pain, ranging from 0 to 10, where 0 indicates no pain and 10 indicates worst imaginable pain. Higher scores indicate worse pain intensity.
Time frame: Postoperative day 1, week 2, week 6, and month 3
Forward Flexion
Active forward flexion of the affected shoulder will be measured in degrees using a goniometer. The participant will raise the arm sideways as far as possible without assistance. At each assessment time point, the measurement will be repeated three times, and the mean of the three values will be recorded. The measured angle will be recorded from 0° to 180°, with higher values indicating greater shoulder range of motion. Change from baseline will be calculated at each prespecified follow-up visit.
Time frame: Postoperative day 1, week 2, week 6, and month 3
Abduction
Active abduction of the affected shoulder will be measured in degrees using a goniometer. The participant will raise the arm sideways as far as possible without assistance. At each assessment time point, the measurement will be repeated three times, and the mean of the three values will be recorded. The measured angle will be recorded from 0° to 180°, with higher values indicating greater shoulder range of motion. Change from baseline will be calculated at each prespecified follow-up visit.
Time frame: Postoperative day 1, week 2, week 6, and month 3
Postoperative Edema Assessed by Relative Shoulder Circumference
Postoperative edema was assessed circumferentially using a non-elastic measuring tape at a standardized point corresponding to the midpoint of the deltoid region. The contralateral shoulder served as the reference. Relative edema was expressed as a percentage and calculated as: \[(operated-side circumference - contralateral-side circumference) / contralateral-side circumference\] × 100. A value of 0% indicated equal circumference between shoulders. Higher positive values indicated greater postoperative edema and a worse outcome, whereas values closer to 0% indicated less edema and a better outcome.
Time frame: Postoperative day 1, week 2, week 6, and month 3
Shoulder Function (Constant-Murley Score)
Shoulder function was assessed using the Constant-Murley Score, which evaluates pain (0-15 points), activities of daily living (0-20 points), range of motion (0-40 points), and strength (0-25 points). The total score ranges from 0 to 100 points. Higher scores indicate better shoulder function and therefore a better outcome, whereas lower scores indicate greater impairment and a worse outcome.
Time frame: Postoperative day 1, week 2, week 6, and month 3
Upper Extremity Function (QuickDASH Score)
Upper extremity function and disability will be assessed using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. The QuickDASH score ranges from 0 to 100, with higher scores indicating greater upper extremity disability and therefore worse functional outcome.
Time frame: Postoperative day 1, week 2, week 6, and month 3
Postoperative Complications
Postoperative complications, including wound problems, infection, clinically important shoulder stiffness, repair-related complications, and tape-related skin reactions, will be recorded. The outcome will be reported as the number and percentage of participants who experience one or more postoperative complications.
Time frame: From the date of surgery through postoperative month 3
Plan to share: No — Individual participant data will not be shared other researchers.
No publications or documents are linked to this record.
Ran from Feb 2026 to primary completion in Jul 2026, 5 months.
Of 228 non-industry interventional studies with no phase under Rotator Cuff Injuries, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 39. This study's 5 months is below that.
Counting every sponsor, half of 252 studies reached it within 23 months; a quarter within 11 and three quarters within 44.
Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 30, 2026: start Dec 2025 → Feb 2026 and primary completion Jun 2026 → Jul 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.